Centre for advanced research in MAternal and child Nutrition using Artificial intelligence and Stable Isotope techniques (MANASI)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2029
Project Lead
Dr. Shalini G Hegde
Authors
Dr. Shalini G Hegde
Project Status
ongoing
Project Type
Centre of Advanced Research (ICMR)